BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11742809)

  • 1. Mutations throughout the S6 region of the hKv1.5 channel alter the stability of the activation gate.
    Rich TC; Yeola SW; Tamkun MM; Snyders DJ
    Am J Physiol Cell Physiol; 2002 Jan; 282(1):C161-71. PubMed ID: 11742809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Episodic ataxia type-1 mutations in the hKv1.1 cytoplasmic pore region alter the gating properties of the channel.
    D'Adamo MC; Liu Z; Adelman JP; Maylie J; Pessia M
    EMBO J; 1998 Mar; 17(5):1200-7. PubMed ID: 9482717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of S6 tail mutations on charge movement in Shaker potassium channels.
    Ding S; Horn R
    Biophys J; 2003 Jan; 84(1):295-305. PubMed ID: 12524283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coupling of voltage sensing to channel opening reflects intrasubunit interactions in kv channels.
    Labro AJ; Raes AL; Snyders DJ
    J Gen Physiol; 2005 Jan; 125(1):71-80. PubMed ID: 15623896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coupling between voltage sensors and activation gate in voltage-gated K+ channels.
    Lu Z; Klem AM; Ramu Y
    J Gen Physiol; 2002 Nov; 120(5):663-76. PubMed ID: 12407078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of an invariant cysteine in gating and ion permeation of the voltage-sensitive K+ channel Kv2.1.
    Zühlke RD; Zhang HJ; Joho RH
    Recept Channels; 1994; 2(3):237-48. PubMed ID: 7874450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of a binding site for quinidine in a human cardiac delayed rectifier K+ channel. Role of S6 in antiarrhythmic drug binding.
    Yeola SW; Rich TC; Uebele VN; Tamkun MM; Snyders DJ
    Circ Res; 1996 Jun; 78(6):1105-14. PubMed ID: 8635242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation gating of Kv4 potassium channels: molecular interactions involving the inner vestibule of the pore.
    Jerng HH; Shahidullah M; Covarrubias M
    J Gen Physiol; 1999 May; 113(5):641-60. PubMed ID: 10228180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of voltage sensitivity by N-terminal cytoplasmic residues in human Kv1.2 channels.
    Varshney A; S K; Mathew MK
    Eur Biophys J; 2002 Sep; 31(5):365-72. PubMed ID: 12202912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scanning the intracellular S6 activation gate in the shaker K+ channel.
    Hackos DH; Chang TH; Swartz KJ
    J Gen Physiol; 2002 Jun; 119(6):521-32. PubMed ID: 12034760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of external pH on activation of the Kv1.5 potassium channel.
    Trapani JG; Korn SJ
    Biophys J; 2003 Jan; 84(1):195-204. PubMed ID: 12524275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different state dependencies of 4-aminopyridine binding to rKv1.4 and rKv4.2: role of the cytoplasmic halves of the fifth and sixth transmembrane segments.
    Tseng GN
    J Pharmacol Exp Ther; 1999 Aug; 290(2):569-77. PubMed ID: 10411564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of voltage-dependent gating and open-state stability in the S5 segment of Shaker potassium channels.
    Kanevsky M; Aldrich RW
    J Gen Physiol; 1999 Aug; 114(2):215-42. PubMed ID: 10435999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Kv channel with an altered activation gate sequence displays both "fast" and "slow" activation kinetics.
    Labro AJ; Grottesi A; Sansom MS; Raes AL; Snyders DJ
    Am J Physiol Cell Physiol; 2008 Jun; 294(6):C1476-84. PubMed ID: 18385285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversed voltage-dependent gating of a bacterial sodium channel with proline substitutions in the S6 transmembrane segment.
    Zhao Y; Scheuer T; Catterall WA
    Proc Natl Acad Sci U S A; 2004 Dec; 101(51):17873-8. PubMed ID: 15583130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine kinases modulate K+ channel gating in mouse Schwann cells.
    Peretz A; Sobko A; Attali B
    J Physiol; 1999 Sep; 519 Pt 2(Pt 2):373-84. PubMed ID: 10457056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of rupatadine, a new dual antagonist of histamine and platelet-activating factor receptors, on human cardiac kv1.5 channels.
    Caballero R; Valenzuela C; Longobardo M; Tamargo J; Delpón E
    Br J Pharmacol; 1999 Nov; 128(5):1071-81. PubMed ID: 10556945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of anorexinogen agents on cloned voltage-gated K(+) channel hKv1.5.
    Perchenet L; Hilfiger L; Mizrahi J; Clément-Chomienne O
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1108-19. PubMed ID: 11504808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of slow activation of the human ether-a-go-go related gene potassium channel.
    Subbiah RN; Clarke CE; Smith DJ; Zhao J; Campbell TJ; Vandenberg JI
    J Physiol; 2004 Jul; 558(Pt 2):417-31. PubMed ID: 15181157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic interaction of S5 and S6 during voltage-controlled gating in a potassium channel.
    Espinosa F; Fleischhauer R; McMahon A; Joho RH
    J Gen Physiol; 2001 Aug; 118(2):157-70. PubMed ID: 11479343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.